Form 4: Director Ross Acquires Shares Through Dividend Equivalent Rights Vesting

Sentiment:

SEC Form 4 Filing


Director Bridget A. Ross acquired shares of LeMaitre Vascular Inc. through the vesting of dividend equivalent rights associated with restricted stock units and performance stock units.

Summary

  • Director Bridget A. Ross acquired shares of LeMaitre Vascular Inc. common stock through the vesting of dividend equivalent rights.
  • These rights were associated with restricted stock unit awards granted on December 11, 2021, and December 12, 2022, as well as a performance stock unit award granted on December 12, 2022.
  • A total of 12 shares were acquired through these transactions, with 6 shares acquired on December 11, 2024, and 3 shares each on December 12, 2024.
  • The shares were acquired at a price of $0, as they were obtained through the vesting of dividend equivalent rights, which are economically equivalent to one share of common stock each.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. It is a positive sign that the director is increasing their stake in the company, but it is not a major event that would significantly impact the sentiment.

Positives

  • The vesting of dividend equivalent rights indicates that performance and time-based vesting conditions have been met.
  • The director's increased shareholding aligns her interests with those of other shareholders.

Industry Context

This filing is a routine disclosure of a director's share acquisition through equity compensation, which is a common practice in publicly traded companies.

Comparison to Industry Standards

  • The use of restricted stock units and performance stock units as part of executive compensation is a standard practice among publicly traded companies, including those in the medical device industry like LeMaitre Vascular.
  • Companies such as Medtronic and Boston Scientific also use similar equity-based compensation plans to align the interests of their executives with those of their shareholders.
  • The vesting of dividend equivalent rights is a common mechanism to ensure that executives receive the economic equivalent of dividends on their unvested shares.

Stakeholder Impact

  • The increased shareholding by a director may be viewed positively by shareholders, as it aligns the director's interests with theirs.

Key Dates

DateDescription
12/11/2021Date of restricted stock unit award grant associated with some of the dividend equivalent rights.
12/12/2022Date of restricted stock unit and performance stock unit award grants associated with some of the dividend equivalent rights.
12/11/2024Date of acquisition of 6 shares through dividend equivalent rights vesting.
12/12/2024Date of acquisition of 6 shares through dividend equivalent rights vesting.
12/13/2024Date of filing of the Form 4.

Keywords

Form 4, Beneficial Ownership, Dividend Equivalent Rights, Restricted Stock Units, Performance Stock Units, Director, LMAT, LeMaitre Vascular Inc.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.